It Is Time to Understand the Additional Benefits of Active Surveillance for Low-Risk Papillary Thyroid Carcinoma.
作者信息
Kim Kyeong Jin
机构信息
Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
出版信息
Endocrinol Metab (Seoul). 2024 Feb;39(1):95-97. doi: 10.3803/EnM.2024.104. Epub 2024 Feb 22.
Abstract
摘要
相似文献
1
It Is Time to Understand the Additional Benefits of Active Surveillance for Low-Risk Papillary Thyroid Carcinoma.
Endocrinol Metab (Seoul). 2024 Feb;39(1):95-97. doi: 10.3803/EnM.2024.104. Epub 2024 Feb 22.
2
Assessing the Number of Candidates There Are for Active Surveillance of Low-risk Papillary Thyroid Cancers in the US.
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):585-586. doi: 10.1001/jamaoto.2020.0523.
3
ASO Author Reflections: Active Surveillance may be Possible in Patients with T1b Papillary Thyroid Carcinoma Over 55 Years of Age Without High-Risk Features on Preoperative Examinations.
Ann Surg Oncol. 2023 Apr;30(4):2254-2255. doi: 10.1245/s10434-022-13047-1. Epub 2023 Jan 11.
4
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Thyroid. 2019 Oct;29(10):1409-1417. doi: 10.1089/thy.2019.0060. Epub 2019 Sep 24.
5
Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active Surveillance: A Systematic Review and Meta-analysis.
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):552-560. doi: 10.1001/jamaoto.2020.0368.
6
Active Surveillance for Low-risk Papillary Thyroid Carcinoma.
JAMA Oncol. 2023 May 1;9(5):722-723. doi: 10.1001/jamaoncol.2023.0003.
7
[Treatment strategy for low-risk papillary thyroid carcinoma with diameter smaller than 1 cm: immediate surgery vs active surveillance].
Zhonghua Yi Xue Za Zhi. 2024 May 14;104(18):1572-1577. doi: 10.3760/cma.j.cn112137-20231113-01075.
8
Thyroidectomy vs Active Surveillance for Subcentimeter Papillary Thyroid Cancers--The Cost Conundrum.
JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):9-10. doi: 10.1001/jamaoto.2015.2852.
9
Active surveillance of low-risk papillary thyroid cancer: A meta-analysis.
Surgery. 2020 Jan;167(1):46-55. doi: 10.1016/j.surg.2019.03.040. Epub 2019 Sep 13.
10
Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives.
Thyroid. 2023 Jul;33(7):826-834. doi: 10.1089/thy.2022.0347. Epub 2023 Mar 21.
引用本文的文献
1
Ultrasonic radiomics in predicting pathologic type for thyroid cancer: a preliminary study using radiomics features for predicting medullary thyroid carcinoma.
Front Endocrinol (Lausanne). 2025 Feb 19;16:1428888. doi: 10.3389/fendo.2025.1428888. eCollection 2025.
本文引用的文献
1
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review.
Endocrinol Metab (Seoul). 2024 Feb;39(1):152-163. doi: 10.3803/EnM.2023.1794. Epub 2024 Jan 22.
2
Long-Term Changes in the Mortality Rates of Thyroid Cancer in Korea: Analysis of Korean National Data from 1985 to 2020.
Endocrinol Metab (Seoul). 2023 Oct;38(5):588-595. doi: 10.3803/EnM.2023.1723. Epub 2023 Sep 8.
3
Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
Ann Surg. 2023 Nov 1;278(5):e1087-e1095. doi: 10.1097/SLA.0000000000005841. Epub 2023 Mar 13.
4
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Thyroid. 2022 Nov;32(11):1328-1336. doi: 10.1089/thy.2021.0614.
6
Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.
World J Surg. 2023 Feb;47(2):392-401. doi: 10.1007/s00268-022-06770-z. Epub 2022 Oct 2.
7
Active surveillance of low-risk papillary thyroid microcarcinoma.
Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101630. doi: 10.1016/j.beem.2022.101630. Epub 2022 Feb 24.
8
Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma.
Endocrinol Metab (Seoul). 2021 Apr;36(2):359-364. doi: 10.3803/EnM.2020.890. Epub 2021 Mar 23.
9
Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Endocrinol Metab (Seoul). 2018 Jun;33(2):278-286. doi: 10.3803/EnM.2018.33.2.278.
10
Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study.
BMJ. 2016 Nov 30;355:i5745. doi: 10.1136/bmj.i5745.
Zotero 插件